永悦科技(603879.SH)控股股東解押2510.76萬股 質押1772萬股
格隆匯7月27日丨永悦科技(603879.SH)公佈,控股股東傅文昌於2020年7月20日將其持有的質押給海通證券的2510.76萬股無限售流通股解除質押,上述解質押已在中國證券登記結算有限責任公司辦理完成了解質押登記手續。
控股股東傅文昌於2020年7月22日將其持有的無限售流通股1772萬股質押給海通證券股份有限公司。
公司控股股東傅文昌持有公司股份5880萬股,佔公司總股本的21.05%。本次解質押及再質押後,控股股東傅文昌處於質押狀態的股份累計1772萬股,佔其所持有公司股份總數的30.14%,佔公司總股本的6.34%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.